Skip to main content
. 2022 Mar;11(3):331–341. doi: 10.21037/tlcr-22-141

Table 2. The managements and situations of PEAF patients at discharge.

Managements and effects Patients Situation of patients at discharge, n (%)
Healing Non-healing Dead
All patients 85 45 (52.9) 20 (23.5) 20 (23.5)
   Surgical management 8 4 (50.0) 1 (12.5) 3 (37.5)
   Stent implantation 25 15 (60.0) 7 (28.0) 3 (12.0)
   Conservative treatment 52 26 (50.0) 12 (23.1) 14 (26.9)
    ICTG 14 9 (64.3) 4 (28.6) 1 (7.1)
    NICTG 38 17 (44.7) 8 (21.1) 13 (34.2)
Type I 16 10 (62.5) 6 (37.5)
   Surgical management 3 1 (33.3) 2 (66.7)
   Stent placement 4 4 (100.0)
   Conservative treatment 9 5 (55.6) 4 (44.4)
Type Ia 5 4 (80.0) 1 (20.0)
   Conservative treatment 5 4 (80.0) 1 (20.0)
Type Ib 11 6 (54.5) 5 (45.5)
   Surgical management 3 1 (33.3) 2 (66.7)
   Stent placement 4 4 (100.0)
   Conservative treatment 4 1 (25.0) 3 (75.0)
Type II 69 35 (50.7) 20 (29.0) 14 (20.3)
   Surgical management 5 3 (60.0) 1 (20.0) 1 (20.0)
   Stent placement 21 11 (52.5) 7 (33.3) 3 (14.3)
   Conservative treatment 43 21 (48.8) 12 (27.9) 10 (23.3)
    ICTG 13 8 (61.5) 4 (30.8) 1 (7.7)
    NICTG 30 13 (43.3) 8 (26.7) 9 (30.0)
Type IIa L1 25 14 (56.0) 6 (24.0) 5 (20.0)
   Surgical management 1 1 (100.0)
   Stent placement 8 5 (62.5) 2 (25.0) 1 (12.5)
   Conservative treatment 16 8 (50.0) 4 (25.0) 4 (25.0)
Type IIa L2 6 1 (16.7) 3 (50.0) 2 (33.3)
   Surgical management 1 1 (100.0)
   Stent placement 1 1 (100.0)
   Conservative treatment 4 1 (25.0) 2 (50.0) 1 (25.0)
Type IIb L1 31 17 (54.8) 9 (29.0) 5 (16.1)
   Surgical management 3 2 (66.7) 1 (33.3)
   Stent placement 11 5 (45.5) 5 (45.5) 1 (9.1)
   Conservative treatment 17 10 (58.8) 4 (23.5) 3 (17.6)
Type IIb L2 7 3 (42.9) 2 (28.6) 2 (28.6)
   Stent placement 1 1 (100.0)
   Conservative treatment 6 2 (33.3) 2 (33.3) 2 (33.3)

PEAF, post-esophagectomy airway fistula; ICTG, interventional conservative treatment group; NICTG, non-interventional conservative treatment group.